DAINIP S'TOMO PHARM (DPM BE) stock market data APIs
€9.8551
0(0%)
as of October 16, 2025
Try our APIs with
free plan!
DAINIP S'TOMO PHARM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for DPM.BE.
Prev. Close
9.8551
Open
9.8551
High
9.8551
Low
9.8551
52 wk Range
2.94-10.5
Market Cap
4 143 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DAINIP S'TOMO PHARM data using free add-ons & libraries
Get DAINIP S'TOMO PHARM Fundamental Data
DAINIP S'TOMO PHARM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DAINIP S'TOMO PHARM News
New
Sumitomo Pharma (TSE:4506) — Assessing Valuation After a 238% Year-to-Date Share Price Surge
Sumitomo Pharma (TSE:4506) shares have been on the move recently, and investors are looking at the stock’s performance amid shifting market conditions. Short-term gains and longer-term returns are b...
Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada
Knight Therapeutics MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has r...
Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada
Knight Therapeutics MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that it h...
Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
President Trump’s 100% tariff on imported branded pharmaceuticals is expected to hit American consumers and global drug stocks, but there are loopholes: Generic drugs are excluded, and there are exe...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
